Calcium Levels Quickly Become Critical for Many Denosumab-Treated Women on Dialysis

(MedPage Today) -- Many women on dialysis quickly developed severe hypocalcemia after starting denosumab (Prolia) for osteoporosis, Medicare data showed. During the first 12 weeks of treatment, 41.1% of women on denosumab developed severe hypocalcemia...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news